DocuSign, Inc. (DOCU)

116.13
NASDAQ
Prev Close 124.44
Day Low/High 115.52 / 122.96
52 Wk Low/High 123.71 / 314.76
Exchange NASDAQ
Shares Outstanding 197.88B
Market Cap 24.62B
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Could the Setup for 2022 Portend an End to the 12-Year Bull Run?

* The setup for 2022 is far different than 2021. * After a lengthy period of unbounded fiscal and monetary largesse we are exiting peak economic activity and peak liquidity * Sell strength and buy weakness? * The growth and narrow market performance...

Evergrande, Markets, Omicron, The Week Ahead, Salesforce, Advanced Micro Devices

Evergrande, Markets, Omicron, The Week Ahead, Salesforce, Advanced Micro Devices

I think I'm likely to remain 'skinny' for now, and prioritize trading over investment at least for the next 10 business days or so.

Play With Fire? You Might Get Burned

Play With Fire? You Might Get Burned

Money-losing companies, even those who have potentially good prospects, are becoming less valuable on an absolute basis by the amount of their losses.

DocuSign Cut at Wolfe

As DocuSign Plunges, Let's Check the Dotted Lines on the Charts

As DocuSign Plunges, Let's Check the Dotted Lines on the Charts

The shares gapped sharply lower Friday after earnings.

Buy the DocuSign Dip?

Macro Issues to the Forefront as Market Participants Deal with Technical Damage

Macro Issues to the Forefront as Market Participants Deal with Technical Damage

The market is dealing with some of the most severe corrective action since the Covid selloff in February 2020.

Sigh of Relief, Recaptured Lines, DocuSign's Big Downer, Marvelous Marvell

Sigh of Relief, Recaptured Lines, DocuSign's Big Downer, Marvelous Marvell

Plus, OPEC plans to open its oil spigot a bit in January and Jerome Powell receives taper support from a few Fed cohorts.

DocuSign Cut at JPMorgan

Omicron Panic, Scared Money, A Tech Bright Spot, Fed Talk, My After-Hours Trades

Omicron Panic, Scared Money, A Tech Bright Spot, Fed Talk, My After-Hours Trades

Whether panicked sales over these past few days, especially Wednesday, prove to be either the 'fast' or 'smart' money remains to be seen.

DocuSign's Trend Has Not Turned

DocuSign's Trend Has Not Turned

Here's what DOCU's charts are saying.

3 Stocks to Watch as Longs in a Market That's Hard to Like

3 Stocks to Watch as Longs in a Market That's Hard to Like

The charts of Livent Corp., Plug Power and PubMatic are of interest for those looking for long plays.

Don't Write Off DocuSign

Don't Write Off DocuSign

While DocuSign has struggled the past few weeks, it may be ready to turn here. Let's take a look at the fine print.

Jim Cramer: Lululemon Is the New Champion When It Comes to Crushing 2019 Numbers

Jim Cramer: Lululemon Is the New Champion When It Comes to Crushing 2019 Numbers

There are not one but two things at work with this company and this stock.

Jobs Day Jolt, So-So Thursday, Manchin Is the Man, DocuSign Language

Jobs Day Jolt, So-So Thursday, Manchin Is the Man, DocuSign Language

Plus, Morgan Stanley sharply lowers its third-quarter GDP expectations and Dr. Fauci provides little COVID comfort.

Stall Speed? Jobs Gut Punch, Taiwan Worries, Mu Variant, Trading AbbVie

Stall Speed? Jobs Gut Punch, Taiwan Worries, Mu Variant, Trading AbbVie

What if areas of expected growth in labor market demand moving forward do not materialize?

DocuSign Could Dip Further Giving Traders a Better Location to Buy

DocuSign Could Dip Further Giving Traders a Better Location to Buy

Here's how to play it now.

Not a Pretty Market

Not a Pretty Market

Whether you can see the ugliness depends on your investments, but here's what I'm spying and why I'm concerned.

Jim Cramer: Nasdaq's Big Second-Quarter Winners Were Written Off Too Soon

Jim Cramer: Nasdaq's Big Second-Quarter Winners Were Written Off Too Soon

These companies were counted out way too early in the post-pandemic environment and the sellers are experiencing some real regret.

Jim Cramer: Here's What Triggered the Torrid Rotation Most Didn't See Coming

Jim Cramer: Here's What Triggered the Torrid Rotation Most Didn't See Coming

It happened around May 12, but strangely, it's finally being talked about and noticed right now.

It's Not Too Late to Get Long or Re-Enter Adobe

It's Not Too Late to Get Long or Re-Enter Adobe

The trick is doing so intelligently.

Jim Cramer: This Is a Market of Stocks, So Shop Around

Jim Cramer: This Is a Market of Stocks, So Shop Around

Let's see what makes an 'aisle' of stocks hot and what makes another messy -- and what I'd suggest you put in your cart.

I See DocuSign as Tradeable With the Potential for Investment

I See DocuSign as Tradeable With the Potential for Investment

But the equity is too risky to invest in ahead of Thursday's earnings numbers tonight.

DocuSign's Charts Have Strengthened

DocuSign's Charts Have Strengthened

Back to the Drawing Board

Jim Cramer: We're Back to the Market That Baffles

Jim Cramer: We're Back to the Market That Baffles

Welcome to the 'new' old world -- the world we had before all the new people and their money came into the market.

Jim Cramer: Johnson & Johnson? Moderna and Pfizer Can Do the Job

Jim Cramer: Johnson & Johnson? Moderna and Pfizer Can Do the Job

You never want to be caught in a counter trend rally.

Jim Cramer: The Disastrous Acceptance Stage Has Hit Individual Investors

Jim Cramer: The Disastrous Acceptance Stage Has Hit Individual Investors

What crushed the individual was a lack of diversification.

Jim Cramer: Look Who's Steel-ing the Show

Jim Cramer: Look Who's Steel-ing the Show

Here's why the institutional stewards of capital who are taking back control of the market are salivating over a dirty old iron company.